1 asset in GBA1-Related Parkinson Disease, Susceptibility
Therapeutic assets addressing GBA1-Related Parkinson Disease, Susceptibility, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Ambroxol GBA1-Related Parkinson Disease, Susceptibility | Agyany Pharma LTD | P2 | BB (64) |